Dr. Zabeti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3113 Bellevue Ave
Ste. 3100
Cincinnati, OH 45219Phone+1 513-475-8730- Is this information wrong?
Education & Training
- Oregon Health & Science UniversityFellowship, Neuroimmunology & Multiple Sclerosis, 2012 - 2013
- West Virginia UniversityResidency, Neurology, 2009 - 2012
- West Virginia UniversityInternship, Transitional Year, 2008 - 2009
- Azad UniversityClass of 1999
Certifications & Licensure
- OR State Medical License 2012 - Present
- CA State Medical License 2017 - 2025
- OH State Medical License 2013 - 2025
- KY State Medical License 2015 - 2025
- WV State Medical License 2011 - 2013
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 8 citationsAssociation of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis.Mahdi Barzegar, Shakiba Houshi, Erfan Sadeghi, Mozhgan Sadat Hashemi, Ghasem Pishgahi
Multiple Sclerosis International. 2022-01-01 - 29 citationsLong-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4–immunoglobulin G–seropositive participants taking ineb...Mary Rensel, Aram Zabeti, Maureen A. Mealy, Daniel Cimbora, Dewei She
Multiple Sclerosis. 2021-10-01 - 167 citationsPhase 2 trial of ibudilast in progressive multiple sclerosisRobert J. Fox, Christopher S. Coffey, Robin Conwit, Merit Cudkowicz, Trevis Gleason
The New England Journal of Medicine. 2018-08-30
Journal Articles
- Phase 2 Trial of Ibudilast in Progressive Multiple SclerosisAram Zabeti, MD, The New England Journal of Medicine
Press Mentions
- Cincinnati Plays Role in Breakthrough Multiple Sclerosis StudyAugust 30th, 2018
- Multiple Sclerosis Drug Slows Brain Shrinkage, Study ShowsAugust 29th, 2018
- Strikeout MS Founders Present $25,000 to UC's Waddell CenterApril 20th, 2018
Professional Memberships
- Member
Other Languages
- Farsi
Hospital Affiliations
- UC Health – West Chester HospitalWest Chester, Ohio
- University of Cincinnati Medical CenterCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: